DealEnveda Biosciences, a Boulder, CO-based drug discovery platform leveraging natural compounds, raised $150 million in a Series D fundraising round led by Premji Invest with participation from Baillie Gifford, Kinnevik, and others.
More on VC News Daily →
OTHER
09/05/2025
Flourish Care, a Boston-based women’s mental health platform, raised...
NanoZymeX, a Basel, Switzerland-based nanobiotech enzyme therapy platform,...
Cellbricks Therapeutics, a Berlin, Germany-based biofabricated tissue...
Ouro Medicines, a Cambridge, MA-based clinical-stage immunology biotech,...
Bioniq, a London-based personalised health platform, was acquired for $150...
Terns Pharmaceuticals, Inc., a Foster City, CA-based leukemia therapy...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
